Zosano Pharma Corporation announced that Steven Lo, will become president and chief executive officer of Zosano effective October 21, 2019. He will also serve on the company's board of directors. Upon retiring after 48 years in the healthcare industry, John Walker will continue as the chairman of the company's board of directors.

Steven Lo was most recently the chief commercial officer at Puma Biotechnology where he built the commercial operations infrastructure to launch the company's first product, NERLYNX, in the United States and executed global licensing deals. Previously, he was senior vice president and chief commercial officer at Corcept Therapeutics.